Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Therapeutics Aps Alteral files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Henrik Rouf - $132K in NORD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Therapeutics Aps Alteral?
Therapeutics Aps Alteral is a corporate insider, tracked as 10% Owner of Nordicus Partners Corp (NORD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Therapeutics Aps Alteral last file a Form 4?
The only primary Form 4 on record is dated 10 December 2024.
